Latest market price
27.28
+0.42+1.56%
OverviewShort InterestFilings
VKTXQT26Viking Therapeutics, Inc.·NASDAQ
27.28+1.56%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 202610-QQuarterly report
Oct 28, 20268-KCurrent report
Sep 28, 20268-KCurrent report
Sep 25, 2026424B5Prospectus
Sep 25, 2026424B5Prospectus
Sep 24, 2026FWPFree writing prospectus
Sep 24, 2026305B2305B2
Sep 23, 2026424B5Prospectus
Sep 23, 2026424B5Prospectus
Sep 22, 20268-KCurrent report
Aug 07, 20263Initial statement of beneficial ownership
Aug 07, 20264Statement of changes in beneficial ownership
Jul 30, 2026S-3ASRS-3ASR
Jul 29, 202610-QQuarterly report
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 20268-KCurrent report
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20263Initial statement of beneficial ownership
May 26, 20268-KCurrent report
Apr 30, 202610-QQuarterly report
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 20268-KCurrent report
Apr 01, 2026ARSAnnual report to shareholders
#1 / 25 of 253
Page
▼
/ 11